Philips Medical Systems and GE Healthcare were hawking cardiological capabilities earlier this month with products aimed at supporting electrophysiology applications. The Philips Allura Xper FD 10 catheterization system and EP MedSystems' EP Workmate,
Philips Medical Systems and GE Healthcare were hawking cardiological capabilities earlier this month with products aimed at supporting electrophysiology applications. The Philips Allura Xper FD 10 catheterization system and EP MedSystems' EP Workmate, shown May 20 to 22 at the Heart Rhythm 2004 meeting in San Francisco, combine EP recording/mapping and fluoroscopy capabilities to help streamline workflow in the EP lab. The Allura Xper FD 10 incorporates fluoro protocols for optimizing dose. The EP WorkMate offers 3D mapping to diagnose and treat cardiac arrhythmias. Philips also highlighted its Live 3D Echo with Tom Tec 4D Left Ventricle-Analysis SW package, which allows the assessment of motion and contraction timing for each region of the left ventricle to help evaluate LV dysynchrony. This analysis can help patients likely to respond to cardiac resynchronization therapy (CRT), a new treatment method for heart failure that uses implantable devices to trigger better pumping efficiency.
At the same meeting, GE unveiled CardioLab IT, a workstation that documents heart monitoring, 3D mapping, and ablation. The company showcased its CardioLab IT CryoCath Interface, which was developed in collaboration with CryoCath Technologies to work with a cryoablation system. The interface automatically captures ablation information and incorporates it into the patient log, synchronizing with waveforms and detailing results.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers
January 8th 2025After propensity score matching in a study of over 3,000 women with a personal history of breast cancer, researchers found that surveillance breast MRI facilitated a 59 percent lower risk in advanced presentations of second breast cancers.